Analgesics in Lithuania

Analgesics sales continued to fall during 2011, albeit at a slower rate than in the previous two years. Consumer price sensitivity, especially amongst older people who account for the majority of sales, resulted in a decline in sales, with many shoppers only being prepared to pay the prices offered during price-slashing campaigns. Overall, due to a lack of innovation regarding new delivery formats or other product attributes, firms competed on price – a development which eroded value sales.

Euromonitor International's Analgesics in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Analgesics Company Shares 2007-2011
Table 4 Analgesics Brand Shares 2008-2011
Table 5 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Sanitas Ab in Consumer Health (lithuania)
Strategic Direction
Key Facts
Summary 1 Sanitas AB: Key Facts
Summary 2 Sanitas AB: Operational Indicators
Company Background
Production
Summary 3 Sanitas AB: Production Statistics 2010
Competitive Positioning
Summary 4 Sanitas AB: Competitive Position 2011
Executive Summary
No Consumer Health Rebound Just Yet
Sales Stagnate As Companies Focus on Lower Income Consumers
Rising Demand for Private Label Brands
Chemists and Pharmacies Continue To Dominate Distribution
Consumer Health Players Facing New Reality
Key Trends and Developments
Discounting Remains Dominant Sales Tactic
Private Label Brands Threaten Branded Goods
Vitamins and Dietary Supplements Attracting Companies
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Self-care and Preventative Medicine
Switches
Summary 5 OTC Healthcare Switches 2009-2011
Definitions
Summary 6 Research Sources Skip to top